Protective effect of resveratrol against hepatic ischemia reperfusion injury in rats and its relationship with Sirt1-p53 signaling pathway

Yi GOU,Tianwu YU,Zhongrong HUANG,Leida ZHANG
DOI: https://doi.org/10.16016/j.1000-5404.201612157
2017-01-01
Abstract:Objective To investigate the effect of resveratrol (RES) on hepatic ischemia reperfusion injury (HIRI) in rats and explore the underlying molecular mechanism.Methods Twenty male SD rats (aged 6 weeks,weighting 200 ± 20 g) were randomly divided into 4 groups (n =5):sham operation group,HIRI group,RES pretreatment group,and RES pretreatment + inhibitor group.The rat model of 70% hot liver ischemia-reperfusion was established through ischemia for 1 h followed by reperfusion for 6 h.RES and Sirt1 inhibitors,EX527 were gave in the rats from the pretreatment group 1 h before the model infliction.Serum ALT activity and SOD activity in liver tissue were detected.The pathological changes of liver tissues were observed by HE staining.The apoptosis of hepatocytes were detected by TUNEL.The expression levels of Sirt1,acetylation p53 and Bax were analyzed by real-time fluorescent quantitative PCR and Western blotting.Results RES significantly reduced the increased ALT activity caused by HIRI (P < 0.01) and enhanced the activity of SOD (P <0.01),alleviated the pathological changes of the liver tissues induced by HIRI (P <0.01),and decreased the apoptosis of liver cells (P <0.01).Moreover,RES obviously increased of the transcriptional levels of Sirt1 and Bax (P < 0.01),improved their protein levels (P < 0.01),but down-regulated the expression of acetylation p53 at protein level (P < 0.01).Conclusion RES attenuates the liver injury induced by ischemia reperfusion,which may be partially through activation of Sirt1-p53 signaling pathway.
What problem does this paper attempt to address?